Table 3.

Effect of varying treatments on IL-17 production (pg/mL) at 48h post NS treatment by peripheral blood mononuclear cells (PBMC) and under the effect of HSV-2 infection. Values are expressed as the means of four experiments ± standard deviations. NS, natural almond skins. nd—not detected. (A) Effect of monoclonal antibodies; (B) Effect of recombinant human (rh) IL-4, IFN-γ and IFN-α.

A	PBMC	+ mAbvs IL-4	+ mAbvsIFN-γ	+ mAbvsIFN-α	+ mAbvsIFN-α and IL-4
HSV-2	48 ± 4.1	86 ± 14.1	nd	nd	nd
NS	<15	41 ± 3.6	<15	116 ± 18.3	207 ± 25.9
NS + HSV-2	<15	54 ± 5.1	<15	167 ± 20.9	309 ± 41.3
B	PBMC	+ rh IL-4	+ rh IFN-γ	+ rh IFN-α	+ rh IFN-α and rh IL-4
HSV-2	48 ± 4.1	38 ± 5.5	51 ± 7.7	19 ± 2.1	<15
NS	<15	<15	<15	<15	<15
NS + HSV-2	<15	<15	<15	<15	<15